Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Related Services at Leva Medical Frequently Asked Questions Retatrutide is the first triple-agonist therapy targeting GLP-1, GIP, and glucagon receptors , while Ozempic (semaglutide) only targets GLP-1 and Mounjaro (tirzepatide) targets GLP-1 + GIP
Pharmaceutical-grade semaglutide and tirzepatide from FDA-approved manufacturers have rigorous quality controls, consistent potency, and verified purity
Others may transition off medication successfully while maintaining stable habits and lifestyle changes
J Ethnopharmacol 2006
Weight reductions of 5% or more, 10% or more, and 15% or more were observed in a high proportion of Retatrutide recipients
US$ 26.85
US$ 21.32
US$ 26.48
US$ 25.09
